Thomas Jefferson University MRIE Pilot Award
Funding Amount
Not stated
Deadline
Deadline not published
Grant Type
Foundation
Deadline history & next window
- Cycle
- Annual
- Tracked since
- April 2026
Source: the cycle recorded on this listing. Confirm dates with the funder.
Overview
Funder: Ocular Melanoma Foundation (direct grants to Thomas Jefferson University through their MRIE program established by Dr. Takami Sato)
Focus Area: Metastatic uveal melanoma research and immunotherapy approaches
Description
Direct research funding provided by OMF to leading institutions such as Thomas Jefferson University through their MRIE (Molecular Research Institute for Oncology or similar) program. These grants support innovative research on metastatic uveal melanoma and immunotherapy development.
Funding Focus
- Humanized mouse models for uveal melanoma immunotherapy research
- Generation and optimization of research models
- Investigation of metastatic uveal melanoma immunity
- Overcoming immunotherapy resistance
- Development of novel animal models with immune systems
Recent Recipients
- 2023: Dr. Mizue Terai - "Generation and Optimization of Humanized Mice to Investigate Metastatic Uveal Melanoma Immunity"
Research Objectives
Aim 1: Generate humanized mice models to study how tumors manipulate their microenvironment
Aim 2: Investigate anti-cancer drug resistance mechanisms
Aim 3: Induce and study efficacy of immunotherapeutics against human metastatic uveal melanoma
What Ocular Melanoma Foundation actually gave
Source: IRS Form 990, 2024
- Grants in 2024
- 4
- Total given
- $50K
- Median grant
- $10K
- Range
- $10K–$20K
- By dollars: California 40%, Pennsylvania 20%, District of Columbia 20%. Top recipient cities: Stanford, CA; Philadelphia, PA; Washington, DC.
Example grants
Stanford Health Care · Stanford, CA
Research
$20K
Thomas Jefferson University and Jefferson Health · Philadelphia, PA
Research
$10K
Melanoma Research Foundation · Washington, DC
Research
$10K
Duke Eye Center · Durham, NC
Research
$10K
Focus Areas & Funding Uses
Fields of Work
- Cancer
- Science research
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
AACR-Ocular Melanoma Foundation Career Development Award
Ocular Melanoma Foundation
Amount
$150,000
Deadline
Deadline not published
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Up to $350,000
Deadline
November 6, 2026
Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
National Institutes of Health
Amount
$50,000 - $300,000
Deadline
November 10, 2026
Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
National Institutes of Health
Amount
$50,000 - $150,000
Deadline
November 10, 2026
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
National Institutes of Health
Amount
Up to $200,000
Deadline
November 17, 2026
Cellular Senescence Network (SenNet): Discovery, Validation Centers (UM1 Clinical Trials Not Allowed)
National Institutes of Health
Amount
$3,400,000 total
Deadline
November 23, 2026
Ready to apply for Thomas Jefferson University MRIE Pilot Award?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found Thomas Jefferson University MRIE Pilot Award. Now let's win it.